Aislinn Antrim is an associate editor at Pharmacy Times®. She graduated from the University of North Carolina at Chapel Hill in 2019 and is completing her master’s in communication and media at Rutgers University.
First Participant Dosed in Phase 1/2 Study of Moderna’s Quadrivalent Seasonal Flu mRNA Vaccine
July 13th 2021The study plans to enroll approximately 180 participants to evaluate the safety, reactogenicity, and immunogenicity of its quadrivalent seasonal influenza mRNA vaccine in adults 18 years and older.
Read More
Upadacitinib Meets Primary Endpoint of Clinical Remission in Patients with Ulcerative Colitis
July 8th 2021Study’s secondary endpoints were also met, including the achievement of endoscopic improvement, histologic-endoscopic mucosal improvement, and corticosteroid-free clinical remission at week 52.
Read More